Salla Pujitha, A. Jaswanth, A. Ganesh, Irfana Begum, Noor Jahan
Salla Pujitha1*, A. Jaswanth2, A. Ganesh3, Irfana Begum4, Noor Jahan5
1Assistant Professor, Department of Pharmacology, Jyothishmathi College of Pharmacy, JNTUH.
2Principal, Department of Pharmacology, Surabhi Dayakar Rao College of Pharmacy, JNTUH.
3Associate Professor, Department of Chemistry, Surabhi Dayakar Rao College of Pharmacy, JNTUH.
4Assistant Professor, Dept. of Pharmacology, Surabhi Dayakar Rao College of Pharmacy, JNTUH.
5Assistant Professor, Department of Quality Assurance, Jyothishmathi College of Pharmacy, JNTUH.
Volume - 8,
Issue - 3,
Year - 2018
PURPOSE-The objective of present study is to explore the anticancer activity of the Ethanolic Extract of the Maytenus emarginata (EEME) in Swiss albino mice against Ehrlich ascites Carcinoma (EAC) cell-line. METHOD-The dose of 100 and 200 mg/kg body weight EEME was administeredintra-peritoneally for nine consecutive days. Twenty-four hours of last dose and 18hrs of fasting, the mice were sacrificed and antitumor effect of EEME was assessed by evaluating tumor volume, viable and non-viable tumor cell count, tumor weight and hematological parameters of EAC bearing host. RESULTS-EEME showed significant decrease in (p<0.01) tumor volume, viable cell count, tumor weight and elevated the life span of EAC tumor bearing mice. Hematological profile such as RBC, hemoglobin, WBC and lymphocyte count reverted to normal level in EEME treated mice. CONCLUSION-From the result it was showed that the extract has potent dose dependent anticancer activity and that is comparable to that of 5-fluorouracil.
Cite this article:
Salla Pujitha, A. Jaswanth, A. Ganesh, Irfana Begum, Noor Jahan. Evaluation of Anticancer activity of Maytenus emarginata on Ehrlich’s Ascites Carcinoma treated mice. Asian J. Res. Pharm. Sci. 2018; 8(3):133-136. doi: 10.5958/2231-5659.2018.00023.1